Novavax Inc. is a biotechnology company focused on developing innovative vaccines to combat infectious diseases. With a strong pipeline of products, including a COVID-19 vaccine candidate, the company is at the forefront of the fight against global pandemics. Novavax’s cutting-edge technology and strong clinical trial results make it a promising player in the biotech industry.
